Evidence map›Paper›PMID 32817524›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Uncovering targeting priority to yeast peroxisomes using an in-cell competition assay.

Mira Rosenthal, Eyal Metzl-Raz, Jérôme Bürgi, Eden Yifrach, Layla Drwesh, Amir Fadel, Yoav Peleg, Doron Rapaport, Matthias Wilmanns, Naama Barkai and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mira RosenthalDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001 Rehovot, Israel.
Eyal Metzl-RazDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001 Rehovot, Israel.ORCID 0000-0002-7111-2822
Jérôme BürgiHamburg Unit c/o DESY, European Molecular Biology Laboratory, 22607 Hamburg, Germany.
Eden YifrachDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001 Rehovot, Israel.ORCID 0000-0001-5074-0048
Layla DrweshInterfaculty Institute of Biochemistry, University of Tübingen, 72074 Tübingen, Germany.
Amir FadelDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001 Rehovot, Israel.
Yoav PelegStructural Proteomics Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, 7610001 Rehovot, Israel.
Doron RapaportInterfaculty Institute of Biochemistry, University of Tübingen, 72074 Tübingen, Germany.
Matthias WilmannsHamburg Unit c/o DESY, European Molecular Biology Laboratory, 22607 Hamburg, Germany.
Naama BarkaiDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001 Rehovot, Israel.
Maya SchuldinerDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001 Rehovot, Israel; maya.schuldiner@weizmann.ac.il einat.zalckvar@weizmann.ac.il.ORCID 0000-0001-9947-115X
Einat ZalckvarDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001 Rehovot, Israel; maya.schuldiner@weizmann.ac.il einat.zalckvar@weizmann.ac.il.

Funding

European Research Council 646604
6 · The paper itself

Abstract

Approximately half of eukaryotic proteins reside in organelles. To reach their correct destination, such proteins harbor targeting signals recognized by dedicated targeting pathways. It has been shown that differences in targeting signals alter the efficiency in which proteins are recognized and targeted. Since multiple proteins compete for any single pathway, such differences can affect the priority for which a protein is catered. However, to date the entire repertoire of proteins with targeting priority, and the mechanisms underlying it, have not been explored for any pathway. Here we developed a systematic tool to study targeting priority and used the Pex5-mediated targeting to yeast peroxisomes as a model. We titrated Pex5 out by expressing high levels of a Pex5-cargo protein and examined how the localization of each peroxisomal protein is affected. We found that while most known Pex5 cargo proteins were outcompeted, several cargo proteins were not affected, implying that they have high targeting priority. This priority group was dependent on metabolic conditions. We dissected the mechanism of priority for these proteins and suggest that targeting priority is governed by different parameters, including binding affinity of the targeting signal to the cargo factor, the number of binding interfaces to the cargo factor, and more. This approach can be modified to study targeting priority in various organelles, cell types, and organisms.

Indexed as

Peroxisomal Targeting SignalsPeroxisomesPeroxisome-Targeting Signal 1 ReceptorProof of Concept StudySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsPeroxisomal Targeting SignalsPeroxisome-Targeting Signal 1 ReceptorPEX5 protein, S cerevisiaeSaccharomyces cerevisiae Proteinsperoxisomesprotein targetingsystems cell biologyyeast

Identifiers

PMID32817524
PMCPMC7474679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.